About

Victoria Nash, PhD, is an Assistant Research Professor in Drexel University’s School of Biomedical Engineering, Science and Health Systems. Dr. Nash's career began in industry, working for Moderna in Cambridge, MA. There, she gained valuable insight into vaccine design and pre-clinical production before returning to academia. During her studies towards her master's degree, Dr. Nash participated in the co-op program at Drexel and was fortunate enough to be the first student to do a co-op at Spark Therapeutics, working in Upstream Process Development. She deepened her knowledge in gene therapy as she worked alongside the industry experts who created the first FDA approved gene therapy to cure childhood blindness. While Dr. Nash enjoyed her work at Spark, she decided to stay in academia to complete her PhD in biomaterials and regenerative medicine, while advised by Kara Spiller, PhD. Her work now focuses on immunomodulatory biomaterials and novel applications of gene and cell therapies.

Link

Organizational Affiliations

School of Biomedical Engineering, Science, and Health Systems, Drexel University

Past Affiliations

Graduate Student, School of Biomedical Engineering, Science, and Health Systems, Drexel University

Moderna Therapeutics (United States) (United States, Cambridge)

Spark Therapeutics (United States) (United States, Philadelphia)

Education

Engineering Science and Biomedical Engineering Devices
BS, Tufts University (United States, Medford)
Biomedical Engineering
MS, Drexel University (United States, Philadelphia)
Biomedical Engineering
PhD, Drexel University (United States, Philadelphia)